First gene therapy for heart failure offered at NewYork-Presbyterian/Columbia

NYC's only medical center offering promising therapy as part of CUPID clinical trial Could injecting a gene into a patient with severe heart failure reverse their disabling and life-threatening condition? Physician-scientists are setting out to answer that question in a first-ever clinical trial of gene therapy to treat severe heart failure.

Read the whole article on Physorg

More from Physorg